======= TIPRL ======= == Gene Information == * **Official Symbol**: TIPRL * **Official Name**: TOR signaling pathway regulator * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=261726|261726]] * **UniProt**: [[https://www.uniprot.org/uniprot/O75663|O75663]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TIPRL&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TIPRL|Open PubMed]] * **OMIM**: [[https://omim.org/entry/611807|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: May be a allosteric regulator of serine/threonine- protein phosphatase 2A (PP2A). Isoform 1 inhibits catalytic activity of the PP2A(D) core complex in vitro. The PP2A(C):TIPRL complex does not show phosphatase activity. Acts as negative regulator of serine/threonine-protein phosphatase 4 probably by inhibiting the formation of the active PPP4C:PPP4R2 complex; the function is proposed to implicate it in DNA damage response by promoting H2AFX phosphorylated on Ser-140 (gamma-H2AFX). May play a role in the regulation of ATM/ATR signaling pathway controlling DNA replication and repair. {ECO:0000269|PubMed:17384681, ECO:0000269|PubMed:26717153}. |TIP41| |TOR signaling| |negative regulation of phosphoprotein phosphatase activity| |negative regulation of protein dephosphorylation| |negative regulation of phosphatase activity| |negative regulation of dephosphorylation| |regulation of phosphoprotein phosphatase activity| |DNA damage checkpoint| |regulation of protein dephosphorylation| |DNA integrity checkpoint| |regulation of phosphatase activity| |cell cycle checkpoint| |regulation of dephosphorylation| |negative regulation of hydrolase activity| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |negative regulation of cell cycle| |negative regulation of protein modification process| |cellular response to DNA damage stimulus| |negative regulation of catalytic activity| |negative regulation of cellular protein metabolic process| |negative regulation of protein metabolic process| |negative regulation of molecular function| |regulation of cell cycle| |regulation of hydrolase activity| |intracellular signal transduction| |cellular response to stress| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of protein modification process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp30|Rapamycin 10μM R00 exp30]]|-2.34| |[[:results:exp75|MK-1775 0.32μM R02 exp75]]|-2.01| |[[:results:exp70|INK128 0.2μM R02 exp70]]|-1.98| |[[:results:exp82|Torin1 0.08μM R02 exp82]]|-1.83| |[[:results:exp400|Senexin-A 25μM R07 exp400]]|1.8| |[[:results:exp242|Radicicol 0.16μM R05 exp242]]|1.82| |[[:results:exp450|Artemisinin 50μM R08 exp450]]|1.83| |[[:results:exp501|Methotrexate 0.01μM R08 exp501]]|1.85| |[[:results:exp310|2-Methoxyestradiol 0.55μM R07 exp310]]|2.01| |[[:results:exp264|Arsenate 40μM R06 exp264]]|2.04| |[[:results:exp460|BML-284 0.09μM R08 exp460]]|2.05| |[[:results:exp301|VER-155008 3.9μM R06 exp301]]|2.06| |[[:results:exp382|Palbociclib 1μM R07 exp382]]|2.1| |[[:results:exp335|Aminopterin 0.005μM R07 exp335]]|2.12| |[[:results:exp458|Bisphenol S 100μM R08 exp458]]|2.2| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|2.36| |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|2.5| |[[:results:exp46|HMS-I1 1μM R01 exp46]]|2.57| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|2.83| |[[:results:exp311|2-Methoxyestradiol 0.55 to 0.75μM on day4 R07 exp311]]|2.85| |[[:results:exp502|Milciclib 2μM R08 exp502]]|3.37| |[[:results:exp312|2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312]]|3.65| |[[:results:exp59|UMK57 1μM R01 exp59]]|4.15| |[[:results:exp67|BVD-523 15μM R02 exp67]]|4.51| |[[:results:exp80|RO-3307 4.7μM R02 exp80]]|5.04| ^Gene^Correlation^ |[[:human genes:p:ppp2r4|PPP2R4]]|0.682| |[[:human genes:l:lcmt1|LCMT1]]|0.604| |[[:human genes:p:ppme1|PPME1]]|0.559| |[[:human genes:c:cyb5r4|CYB5R4]]|0.474| |[[:human genes:p:ppp6r3|PPP6R3]]|0.448| |[[:human genes:p:ppp2r1a|PPP2R1A]]|0.439| Global Fraction of Cell Lines Where Essential: 20/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|1/26| |breast|1/33| |central nervous system|2/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|1/16| |kidney|1/21| |liver|2/20| |lung|0/75| |lymphocyte|0/16| |ovary|1/26| |pancreas|1/24| |peripheral nervous system|1/16| |plasma cell|0/15| |prostate|0/1| |skin|4/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|2/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1864 * **Expression level (log2 read counts)**: 5.86 {{:chemogenomics:nalm6 dist.png?nolink |}}